Detection of PDGFRA mutations at exons 12 and 18 among chronic myeloid leukemia patients treated with imatinib mesylate
Imatinib mesylate (IM) resistance is an emerging and major challenge in the treatment of patients with chronic myeloid leukaemia (CML). Resistance toward IM can be divided into BCR-ABL dependent pathways and BCR-ABL independent pathway. In this study, the BCRABL independent pathway was investigated;...
Main Author: | Razali, Ruzi Hamimi |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://eprints.usm.my/39897/1/Dr_Ruzi_Hamimi_Razali_%28Medical_Genetics%29-24_pages.pdf |
Similar Items
-
Imatinab mesylate treatment in Chronic Myeloid
Leukemia (CML)- understanding the
fundamental pharmacokinetic and
pharmacogenetic mechanisms for variation in
response
by: Ankathil, Ravindran
Published: (2016) -
Analysis Of P27 And Cyclin D1 Genes In Gliomas And Meningiomas Using Molecular Genetic, Immunohistochemical And Immunogold Electron Microscopic Techniques [RC267. F228 2008 f rb].
by: Ahmad, Farizan
Published: (2008) -
A Mammogram And Breast Ultrasound-Based Expert System With Image Processing Features For Breast Diseases [ RC280.B8 U51 2007 f rb ].
by: Ngah, Umi Kalthum
Published: (2007) -
Glutamate regulation of Voltage-Gated Sodium Channels (VGSCS) in breast cancer cell lines of different metastatic potential
by: Azahar, Irfan Irsyad
Published: (2022) -
Assessment on awareness of ovarian
cancer risk factors and attitudes
towards screening among women in
Balik Pulau, Penang
by: Wahab, Syakirah Bainun Abdul
Published: (2014)